Skip to main content

Table 5 Comparison of the clinical characteristics of chronic hepatitis C patients with or without hepatic steatosis (≥5%)

From: Serum levels of apoptosis inhibitor of macrophage are associated with hepatic fibrosis in patients with chronic hepatitis C

  

Steatosis (<5%)

  

Steatosis (≥5%)

  
  

n = 59

  

n = 18

  

Factor

Mean or number

Maximum

Minimum

Mean or number

Maximum

Minimum

P value*

Age (years)

55.2

76

20

59.1

69

33

0.257

Sex (male/female)

26/33

  

5/13

  

0.217

Body mass index (kg/m2)

22.3

30.1

16.4

23.8

32.2

19.9

0.800

Platelet count (×104/μl)

18.3

41.9

7.4

17.1

36.2

5.4

0.434

Total cholesterol (mg/dl)

171.4

295

84

168.4

222

114

0.814

Albumin (g/dl)

4.3

5.1

3.3

4.0

4.9

2.9

0.023

ALT (IU/l)

63.1

244

13

69.1

191

20

0.125

γ-GTP (IU/l)

40.6

239

12

81.4

468

12

0.010

Diabetes (absent/present)

50/9

  

10/8

  

0.009

Fasting plasma glucose (mg/dl)

95.9

196

72

100.8

150

80

0.145

Hemoglobin A1c (%)

5.3 (n = 57)

7.6

4.6

5.6

7.1

4.7

0.084

Leptin (ng/ml)

7.0

21.8

1.0

9.6

17.3

3.5

0.006

Adiponectin (ng/ml)

9.3

27.3

1.1

8

26.1

1.7

0.493

Resistin (ng/ml)

8.1

27.6

2.5

9.9

17.5

4

0.042

AIM (μg/ml)

1.37

4.56

0.41

1.43

6.44

0.72

0.290

Hyaluronic acid (ng/ml)

71.9 (n = 57)

292.7

10

171.6

636.0

11.2

0.021

  1. *Calculated by Chi-square test for categorical variables or Mann–Whitney U test for continuous variables.
  2. ALT, alanine aminotransferase; γGTP, γ-glutamyl transpeptidase; HOMA-IR, homeostasis model assessment-insulin resistance; AIM, apoptosis inhibitor of macrophage.